INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Awaiting price reaction for this filing.
Eris Lifesciences Limited has informed the stock exchanges about an upcoming virtual meeting with Franklin Templeton Mutual Fund scheduled for Monday, June 16, 2025. The meeting falls under the institutional investor category and is being conducted in compliance with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The company has clarified that only publicly available information will be discussed and no unpublished price-sensitive information (UPSI) will be shared. The filing was signed by Milind Talegaonkar, Company Secretary and Compliance Officer, on June 11, 2025.
This is a routine regulatory disclosure and not expected to move the stock price on its own. However, it signals ongoing engagement with large institutional investors like Franklin Templeton, which is generally viewed positively by the market.